Drug Prices, Trump and Yellen, and Junk Science

Barry Ritholtz is a Bloomberg View columnist. He founded Ritholtz Wealth Management and was chief executive and director of equity research at FusionIQ, a quantitative research firm. He blogs at the Big Picture and is the author of “Bailout Nation: How Greed and Easy Money Corrupted Wall Street and Shook the World Economy.”
Read More.
a | A

Finish your week strong with our morning train reads:

  • How Humans Became "Consumers": A History. Until the 19th century, hardly anyone recognized the vital role everyday buyers play in the world economy. (the Atlantic)
  • The Great Asset Management Consolidation of 2016 (Chief Investment Officer)
  • Australian boys re-create $100,000 life-saving drug for $20 (BBC); see also The true story of America’s sky-high prescription drug prices (Vox)
  • Can Trump and Yellen Be Friends? Against all odds, Yellen could be an ally to Trump in accelerating growth. Or not. (Bloomberg Businessweek)
  • 6 Financial Must-Dos Before Year-End (Morningstar)
  • Ten Good Pieces of Economic Data From All Around the World (Bloomberg); see also Trump is about to inherit the "strongest overall job market in a generation" (Business Insider)
  • New secretary of Health and Human Services is a member of a fringe medical organization. Here’s what that means. (Science Blogs)
  • Flying cars are closer than you think (the Verge)
  • Examples of Junk Science: A Pseudoscience Whistleblower Story (Political Calculations)
  • 100 Outstanding Audio Stories of 2016 (Bello Collective)

Be sure to check out our Masters in Business podcast with James Gleick, author of numerous award-winning books, including "The Information: A History, A Theory, A Flood" and, most recently, "Time Travel: A History."

Absent From Trump Rally in Stocks? Insider Buying

Want to receive our daily reads in your inbox? Sign up here!

This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.

To contact the author of this story:
Barry Ritholtz at britholtz3@bloomberg.net

To contact the editor responsible for this story:
Brooke Sample at bsample1@bloomberg.net